14-day Premium Trial Subscription Sign Up For FreeGet Free

Stock Market Week 20 - The Game Is On! Click to watch.

Catalyst Pharmaceuticals Stock Forecast

NASDAQ:CPRX BUY SELL

$7.00 (1.30%)

Volume: 1.147M

Closed: May 16, 2022

Hollow Logo Score: -2.263

Catalyst Pharmaceuticals Stock Forecast

BUY SELL NASDAQ:CPRX
$7.00 (1.30%)

Volume: 1.147M

Closed: May 16, 2022

Score Hollow Logo -2.263

Catalyst Pharmaceuticals Stock Forecast NASDAQ:CPRX

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-02-08 71.43% HC Wainwright & Co. $9.00 $12.00 Maintains Buy
2021-03-18 0% Roth Capital $6.50 $7.00 Maintains Buy
2020-08-12 14.29% Truist Securities $10.00 $8.00 Maintains Buy
2020-05-13 42.86% SunTrust Robinson Humphrey $11.00 $10.00 Maintains Buy
2020-02-14 71.43% Cantor Fitzgerald $11.00 $12.00 Reiterates Overweight

CPRX Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -3.87% during the next 3 months and, with a 90% probability hold a price between $6.24 and $8.12 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-18 $6.49 $7.46 $8.44
2022-05-19 $6.48 $7.46 $8.43
2022-05-20 $6.48 $7.45 $8.43
2022-05-23 $6.47 $7.45 $8.42
2022-05-24 $6.46 $7.44 $8.42
2022-05-25 $6.46 $7.44 $8.41
2022-05-26 $6.45 $7.43 $8.41
2022-05-27 $6.45 $7.42 $8.40
2022-05-31 $6.44 $7.42 $8.39
2022-06-01 $6.44 $7.41 $8.39
2022-06-02 $6.43 $7.41 $8.38
2022-06-03 $6.43 $7.40 $8.38
2022-06-06 $6.42 $7.40 $8.37
2022-06-07 $6.41 $7.39 $8.37
2022-06-08 $6.41 $7.38 $8.36
2022-06-09 $6.40 $7.38 $8.35
2022-06-10 $6.40 $7.37 $8.35
2022-06-13 $6.39 $7.37 $8.34
2022-06-14 $6.39 $7.36 $8.34
2022-06-15 $6.38 $7.36 $8.33
2022-06-16 $6.37 $7.35 $8.33
2022-06-17 $6.37 $7.34 $8.32
2022-06-21 $6.36 $7.34 $8.32
2022-06-22 $6.36 $7.33 $8.31
2022-06-23 $6.35 $7.33 $8.30
2022-06-24 $6.35 $7.32 $8.30
2022-06-27 $6.34 $7.32 $8.29
2022-06-28 $6.33 $7.31 $8.29
2022-06-29 $6.33 $7.31 $8.28
2022-06-30 $6.32 $7.30 $8.28

About Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Catalyst Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies for people with rare debilitating diseases. Its lead product candidate is Firdapse, a proprietary form of amifampridine phosphate, which completed Phase III clinical trial for the treatment of patients with Lambert-Eaton Myasthenic syndrome; and is in small blinded clinical trial to treat Congenital Myasthenic syndromes, as w... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 108 000+ Happy Subscribers

Don't miss out on the runners!

Sign for StockInvest.us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT